A Surprising Ally: Diabetes Drugs Battle Dementia
Research from Korea indicates SGLT-2 inhibitors not only manage type 2 diabetes but may also reduce the risk of dementia by 35% compared to DPP-4 inhibitors. With dementia cases expected…
Research from Korea indicates SGLT-2 inhibitors not only manage type 2 diabetes but may also reduce the risk of dementia by 35% compared to DPP-4 inhibitors. With dementia cases expected…